Literature DB >> 26778356

Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.

Vera Fominykh1, Mikhail V Onufriev2, Anna Vorobyeva3, Lev Brylev2, Alexander A Yakovlev2, Maria N Zakharova3, Natalia V Gulyaeva2.   

Abstract

Multiple sclerosis (MS) is an immune-mediated disorder associated with inflammation, demyelination and axonal damage. In search of potential biomarkers of spinal cord lesions in MS related to nitric oxide metabolites, we measured total nitrite and nitrate levels, and protein-bound nitrotyrosine and S-nitrosothiol concentrations in the serum of MS patients at different stages of the disease. Sixty-eight patients and 36 healthy volunteers were included in the study. Total nitrite and nitrate levels were augmented in relapsing-remitting MS, while increased S-nitrosothiol concentrations were found both in relapsing-remitting and secondary-progressive MS. Further analysis demonstrated that S-nitrosothiol levels were selectively increased in patients with spinal cord injury. The data suggest that high S-nitrosothiol concentration may be a potential serum biomarker for spinal cord injury in MS.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multiple sclerosis; Nitric oxide; S-nitrosothiols; Spinal cord

Mesh:

Substances:

Year:  2016        PMID: 26778356     DOI: 10.1016/j.jocn.2015.09.017

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Nitrosative stress parameters and the level of oxidized DNA bases in patients with multiple sclerosis.

Authors:  Vitalijs Borisovs; Jevgenijs Bodrenko; Jolanta Kalnina; Nikolajs Sjakste
Journal:  Metab Brain Dis       Date:  2021-08-21       Impact factor: 3.584

2.  Interleukin-6, S-Nitrosothiols, and Neurodegeneration in Different Central Nervous System Demyelinating Disorders: Is There a Relationship?

Authors:  Vera Fominykh; Anna Vorobyeva; Mikhail V Onufriev; Lev Brylev; Maria N Zakharova; Natalia V Gulyaeva
Journal:  J Clin Neurol       Date:  2018-05-31       Impact factor: 3.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.